- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02530528
Pilot Trial of Preoperative Chlorhexidine Gluconate (CHG) Skin Preparation
April 28, 2021 updated by: Medline Industries
Pilot Trial Assessment of the Antimicrobial Efficacy of Medline 2% CHG Cloth Preoperative Skin Preparation
Pilot study to evaluate and compare activity of investigational preoperative preparation (2% CHG) with comparator (2% CHG).
Study Overview
Detailed Description
Evaluate and compare similar preoperative surgical preparations in healthy volunteers.
Various application times were evaluated.
Efficacy was assess using the Tentative Final Monograph (TFM) criteria.
Study Type
Interventional
Enrollment (Actual)
27
Phase
- Phase 2
- Phase 1
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
16 years and older (Child, Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Healthy
- No dermatological conditions
Exclusion Criteria:
- Sensitivity to CHG
- Sensitivity to natural latex rubber or adhesive skin products
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: 2% CHG 1 min
single administration, 1 min application time
|
Varied application times
Other Names:
|
Experimental: 2% CHG 2 min
single administration, 2 min application time
|
Varied application times
Other Names:
|
Experimental: 2% CHG 3 min
single administration, 3 min application time
|
Varied application times
Other Names:
|
Active Comparator: Comparator 2% CHG
Single administration, Marketed CHG
|
Varied application times
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Log Reduction of Bacterial Flora on Abdomen and Groin Sites
Time Frame: 10 min, 6 hr and 8 hr
|
Evaluate the Log Reduction of Normal Flora at various sites and timepoints
|
10 min, 6 hr and 8 hr
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Bashir M Hamid, MD, Microbac Laboratories
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
February 1, 2014
Primary Completion (Actual)
April 1, 2014
Study Completion (Actual)
April 1, 2014
Study Registration Dates
First Submitted
August 16, 2015
First Submitted That Met QC Criteria
August 19, 2015
First Posted (Estimate)
August 21, 2015
Study Record Updates
Last Update Posted (Actual)
April 30, 2021
Last Update Submitted That Met QC Criteria
April 28, 2021
Last Verified
September 1, 2020
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- R13-042
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Surgery
-
3MRecruitingAbdominal Surgery | Orthopedic Surgery | Vascular Surgery | Cardiovascular SurgeryUnited States
-
Vanderbilt UniversityCompletedHand Surgery | Wrist Surgery | Forearm Surgery | Elbow SurgeryUnited States
-
Nantes University HospitalCompletedGynecological Surgery | Plastic Surgery | ENT SurgeryFrance
-
Edwards LifesciencesCompletedAbdominal Surgery | Pelvic Surgery | Non-Cardiac/ Non-Thoracic Surgery | Major Peripheral Vascular SurgeryUnited States
-
Maquet Cardiopulmonary GmbHNAMSARecruitingCardiac Surgery | Cardiopulmonary Bypass | Thoracic Surgery | Vascular SurgerySpain
-
Baylor Research InstituteChiesi USA, Inc.RecruitingSurgery | Cardiac Surgery | Surgery--Complications | Percutaneous Coronary InterventionUnited States
-
Vanderbilt UniversityEdwards LifesciencesCompletedCardiac Surgery | Thoracic Surgery | Heart Surgery | Heart Transplant
-
Cairo UniversityBatterjee Medical College; Taif UniversityCompletedSurgery | Bariatric SurgeryEgypt, Saudi Arabia
-
Surgify Medical OyCompletedSurgery | Spine SurgeryFinland
-
Poudre Valley Health SystemTerminatedSurgery | Surgery--ComplicationsUnited States
Clinical Trials on CHG
-
National Taiwan University HospitalMin-Sheng General Hospital; Lotung Poh-Ai Hospital; Hualien Tzu Chi General Hospital and other collaboratorsRecruiting
-
University Hospital, GrenobleCompletedCatheter-Related InfectionsFrance
-
Catholic University of the Sacred Heart3M; Fondazione C.N.R./Regione Toscana "G. Monasterio", Pisa, ItalyUnknownInfection | CatheterizationItaly
-
3MCompleted
-
Duke UniversityCompletedCentral Line-associated Bloodstream Infection (CLABSI)United States
-
Icahn School of Medicine at Mount SinaiCompletedEndometritis | Surgical Site Infections | Infection; Cesarean Section | Chlorhexidine Gluconate Cloths | Infectious MorbidityUnited States
-
3MTerminatedSkin Flora Bacterial Reduction Post-product ApplicationUnited States
-
University Hospital OstravaCompletedSurgery | Multiorgan Failure | Haematologic DiseaseCzechia